In final draft guidance, NICE has approved Perjeta – given in combination with trastuzumab and chemotherapy – as a new option after surgery for some...

15 February 2019

Our research has provided strong evidence that women aged 35-39 at a moderate or high risk of developing breast cancer, could benefit from annual...

11 February 2019

A leading Manchester scientist has been awarded a prestigious fellowship by Breast Cancer Now to investigate whether targeting two key proteins could...

4 February 2019

Two leading Bradford scientists have been awarded a combined total of more than £280,000 by research charity Breast Cancer Now, to develop a new type...

4 February 2019

Researchers part-funded by Breast Cancer Now have identified changes in breast cancer cells that could in future help predict the likelihood of...

21 January 2019

The two-week wait for people referred with suspected breast cancer was missed. The target is 93%, but only 90.51% of patients were seen within two...

11 January 2019

Leading support charity Breast Cancer Care has today (Wednesday 9 January 2019) launched an online toolkit for secondary breast cancer nurses across...

10 January 2019

New figures released today by national charity Breast Cancer Care reveal the devastating impact on women with breast cancer of conflicting...

8 January 2019

Targeted antibody therapies – including a new antibody immunotherapy – could offer “long-awaited” advances for patients with aggressive ‘triple...

17 December 2018